Abstract
Background
A consensus has not been reached on the association between weight loss and survival outcomes in patients with heart failure (HF). This meta-analysis aimed to assess the association of weight loss with cardiovascular or all-cause mortality in patients with HF.
Methods
Two authors independently searched the articles indexed in the PubMed and Embase databases up to May 7, 2023. Post hoc analysis of randomized controlled trials or observational studies that reported the utility of weight loss in predicting cardiovascular or all-cause mortality in patients with HF were included.
Results
Thirteen studies reporting on 12 articles involving 26,164 patients with HF were included. A comparison of weight loss with stable weight showed that the pooled adjusted hazard ratio (HR) for all-cause mortality was 1.75 (95% confidence intervals [CI] 1.43-2.14). Subgroup analysis revealed that weight loss was associated with an increased risk of all-cause mortality, irrespective of whether patients were overweight/obese (HR 1.76; 95% CI 1.41-2.20) or not (HR 1.90; 95% CI 1.14-3.14). The pooled adjusted HR of cardiovascular mortality was 1.64 (95% CI 1.18-2.28) for patients with weight loss compared to those without.
Conclusions
Weight loss is associated with an increased risk of cardiovascular and all-cause mortality in patients with HF. Assessing weight changes can provide prognostic information for patients with HF.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The available data and materials section refers to the raw data used in this study are included in the manuscript and supplemental material.
References
Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021;23:352–80.
Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13:368–78.
Tsutsui H. Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines. Pharmacol Ther. 2022;238:108185.
Jamaly S, Carlsson L, Peltonen M, Andersson-Assarsson JC, Karason K. Heart failure development in obesity: underlying risk factors and mechanistic pathways. ESC Heart Fail. 2021;8:356–67.
Tabucanon T, Wilcox J, Tang WHW. Does weight loss improve clinical outcomes in overweight and obese patients with heart failure? Curr Diab Rep. 2020;20:75.
McDowell K, Petrie MC, Raihan NA, Logue J. Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obes Rev. 2018;19:1189–204.
Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151–6.
Simonenko M. Obesity paradox in heart failure: a matter of debate. Eur J Prevent Cardiol. 2019;26:1748–50.
Hweidi IM, Al-Omari AK, Rababa MJ, Al-Obeisat SM, Hayajneh AA. Cardiac cachexia among patients with chronic heart failure: a systematic review. Nurs Forum. 2021;56:916–24.
Song EK, Lee Y, Moser DK, Dekker RL, Kang SM, Lennie TA. The link of unintentional weight loss to cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs. 2014;29:439–47.
Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–3.
Trullas JC, Formiga F, Montero M, Carrera-Izquierdo M, Grau-Amoros J, Chivite-Guillen D, et al. Impact of weight loss on mortality in chronic heart failure: findings from the RICA Registry. Int J Cardiol. 2013;168:306–11.
Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060–7.
Vidan MT, Blaya-Novakova V, Sanchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016;18:869–75.
Okuhara Y, Asakura M, Orihara Y, Naito Y, Tsujino T, Ishihara M, et al. Effects of weight loss in outpatients with mild chronic heart failure: findings from the J-MELODIC study. J Card Fail. 2019;25:44–50.
Niedziela JT, Hudzik B, Strojek K, Polonski L, Gasior M, Rozentryt P. Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes. J Cachexia Sarcopenia Muscle. 2019;10:1307–15.
Huang P, Guo Z, Liang W, Wu Y, Zhao J, He X, et al. Weight change and mortality risk in heart failure with preserved ejection fraction. Front Cardiovasc Med. 2021;8:681726.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
Vanderschueren S, Geens E, Knockaert D, Bobbaers H. The diagnostic spectrum of unintentional weight loss. Eur J Intern Med. 2005;16:160–4.
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed August 18, 2023).
Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077–83.
Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:2641–50.
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, et al. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail. 2015;17:424–33.
Zamora E, Diez-Lopez C, Lupon J, de Antonio M, Domingo M, Santesmases J, et al. Weight loss in obese patients with heart failure. J Am Heart Assoc. 2016;5:e002468.
Kamisaka K, Kamiya K, Iwatsu K, Iritani N, Imoto S, Adachi T, et al. Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study. ESC Heart Fail. 2021;8:5293–303.
Ferreira JP, Rossignol P, Claggett BL, Solomon SD, Pitt B, Pfeffer M, et al. Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT. Clin Res Cardiol. 2022;111:451–9.
Anker SD, Khan MS, Butler J, Ofstad AP, Peil B, Pfarr E, et al. Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced. Eur J Heart Fail. 2023;25:117–27.
Tager T, Franke J, Frey N, Frankenstein L, Frohlich H. Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failure. Nutr Metab Cardiovasc Dis. 2023;33:416–23.
Tutor AW, Lavie CJ, Kachur S, Milani RV, Ventura HO. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2023;78:2–10.
Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162:501–12.
Mottel BH, Lindsay DA, Frishman WH. Effect of bariatric surgery on cardiovascular function and heart failure outcomes. Cardiol Rev. 2021;29:187–94.
Joho S, Ushijima R, Nakagaito M, Kinugawa K. Sympathetic overactivation predicts body weight loss in patients with heart failure. Auton Neurosci. 2020;223:102625.
Sharma A, Ambrosy AP, DeVore AD, Margulies KB, McNulty SE, Mentz RJ, et al. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. ESC Heart Fail. 2018;5:1035–43.
Boxall BW, Clark AL. Beta-blockers and weight change in patients with chronic heart failure. J Card Fail. 2012;18:233–7.
Schellenbaum GD, Smith NL, Heckbert SR, Lumley T, Rea TD, Furberg CD, et al. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. J Am Geriatr Soc. 2005;53:1996–2000.
Kokkinos P, Faselis C, Pittaras A, Samuel IBH, Lavie CJ, Vargas JD, et al. Cardiorespiratory fitness and risk of heart failure with preserved ejection fraction. Eur J Heart Fail. 2023. https://doi.org/10.1002/ejhf.3117. Online ahead of print.
Carbone S, daSilva-deAbreu A, Lavie CJ. Weighing in on weight loss in heart failure with reduced ejection fraction. Eur J Heart Fail. 2023;25:128–30.
Ventura HO, Carbone S, Lavie CJ. Muscling up to improve heart failure prognosis. Eur J Heart Fail. 2018;20:1588–90.
Lavie CJ, Carbone S, Neeland IJ. Prevention and treatment of heart failure: we want to pump you up. JACC Cardiovasc Imaging. 2021;14:216–8.
Author information
Authors and Affiliations
Contributions
Study conception/design and interpretation of data: Xinhua Hu; Literature search, data extraction, quality assessment, statistical analysis: Xinyue Wu and Yuxin Wang; Writing the manuscript: Xinyue Wu. Revising the manuscript: Yuxin Wang. All the authors approved the version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, X., Wang, Y. & Hu, X. Association of weight loss with cardiovascular or all-cause mortality in patients with heart failure: A meta-analysis. Int J Obes (2024). https://doi.org/10.1038/s41366-024-01484-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41366-024-01484-9